SCHEMBL609604

SCHEMBL609604

COc1ccccc1C=CC(=O)C=C(O)C=Cc1ccccc1OC

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 4/20 0.78
TFEB P19484 1/20 0.78
MAPT P10636 4/20 0.68
NPC1 O15118 3/20 0.68
KDM4E B2RXH2 2/20 0.68
RAB9A P51151 2/20 0.68
MAPK1 P28482 2/20 0.68
ATM Q13315 1/20 0.68
NPSR1 Q6W5P4 1/20 0.68
TDP1 Q9NUW8 1/20 0.68
LY96 Q9Y6Y9 2/20 0.66
LMNA P02545 2/20 0.65
BCHE P06276 1/20 0.65
MAOB P27338 3/20 0.56
AR P10275 1/20 0.56
CYP1A2 P05177 3/20 0.55
CYP2D6 P10635 3/20 0.55
HPGD P15428 3/20 0.55
CYP1A1 P04798 2/20 0.55
CYP1B1 Q16678 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL609603 1.00 NFE2L2 (0.78) NFE2L2TFEBMAPTNPC1KDM4E
SCHEMBL2744047 0.88 NFE2L2 (1.00) NFE2L2TFEBMAPTNPC1KDM4E
SCHEMBL30307386 0.88 NFE2L2 (1.00) NFE2L2TFEBMAPTNPC1KDM4E
SCHEMBL2744044 0.88 NFE2L2 (1.00) NFE2L2TFEBMAPTNPC1KDM4E
SCHEMBL16403662 0.88 NFE2L2 (1.00) NFE2L2TFEBMAPTNPC1KDM4E
SCHEMBL29805195 0.88 NFE2L2 (1.00) NFE2L2TFEBMAPTNPC1KDM4E
SCHEMBL14571866 0.86 NFE2L2 (0.80) NFE2L2TFEBMAPTNPC1KDM4E
SCHEMBL608596 0.83 JUN (0.57) NFE2L2TFEBMAPTNPC1KDM4E
SCHEMBL608597 0.83 JUN (0.57) NFE2L2TFEBMAPTNPC1KDM4E
Coumarinic Acid Methyl Ether SCHEMBL79060 0.83 NFE2L2 (0.77) NFE2L2TFEBMAPTNPC1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11596716-B2 Compounds and matrices for use in bone growth and repair HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2023-03-07 US disclosed
US-20210138117-A1 COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2021-05-13 US disclosed
US-10874766-B2 Compounds and matrices for use in bone growth and repair HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2020-12-29 US disclosed
EP-3038621-B1 COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR HUMAN BIOMOLECULAR RES INSTITUTE (US) 2020-12-02 EP disclosed
EP-3038621-A2 COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR Human Biomolecular Research Institute (US) 2016-07-06 EP disclosed
US-20160038641-A1 COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2016-02-11 US disclosed
WO-2014146039-A2 COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2014-09-18 WO disclosed
US-20120040976-A1 SMALL MOLECULE IMMUNOMODULATORS FOR ALZHEIMER'S DISEASE HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2012-02-16 US disclosed
US-20090263492-A1 Diagnostic Methods and Genetic Markers for Alzheimer Disease HUMAN BIOMOLECULAR RESEARCH INSTITUTE 2009-10-22 US disclosed
WO-2008048410-A9 DIAGNOSTIC METHODS AND GENETIC MARKERS FOR ALZHEIMER DISEASE HUMAN BIOMOLECULAR RES INST (US) 2008-06-26 WO disclosed
WO-2008048410-A2 DIAGNOSTIC METHODS AND GENETIC MARKERS FOR ALZHEIMER DISEASE HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2008-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10874766-B2 Compounds and matrices for use in bone growth and repair BMP2, BMP4, BMP6 NFE2L2 1522/4885TFEB 2012/4885MAPT 4729/4885
US-11596716-B2 Compounds and matrices for use in bone growth and repair BMP2, BMP4, BMP6 NFE2L2 1181/4885TFEB 1725/4885MAPT 4739/4885
US-20090263492-A1 Diagnostic Methods and Genetic Markers for Alzheimer Disease CHAT, SLC18A3, GAP43 NFE2L2 2656/4885TFEB 2423/4885MAPT 30/4885
US-20210138117-A1 COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR BMP2, BMP4, BMP6 NFE2L2 1181/4885TFEB 1725/4885MAPT 4739/4885
US-20160038641-A1 COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR BMP2, BMP4, BMP6 NFE2L2 1486/4885TFEB 1658/4885MAPT 4725/4885
US-20120040976-A1 SMALL MOLECULE IMMUNOMODULATORS FOR ALZHEIMER'S DISEASE L1CAM, LY96, GMFG NFE2L2 2405/4885TFEB 1505/4885MAPT 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.